Venlafaxine ER 37.5mg Capsules

Manufacturer AUROBINDO PHARMA Active Ingredient Venlafaxine Extended-Release Capsules(ven la FAX een) Pronunciation VEN-la-FAX-een
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It is used to treat panic attacks.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant
đŸ§Ŧ
Pharmacologic Class
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
🤰
Pregnancy Category
Category C
✅
FDA Approved
Sep 1997
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Venlafaxine ER is an antidepressant medication that works by affecting certain chemicals in the brain (serotonin and norepinephrine) that can become unbalanced and cause symptoms of depression or anxiety. The 'ER' means extended-release, so it releases the medicine slowly over time, allowing you to take it once a day.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.

Take your medication with food to help your body absorb it properly.
Swallow the capsule whole - do not crush, chew, or dissolve it.
If you have trouble swallowing the capsule, you can sprinkle its contents onto a small amount of applesauce. However, do not chew the mixture. Swallow it immediately and follow with a glass of cool water.

It's essential to establish a routine when taking your medication. Take it at the same time every day, and continue taking it as directed by your doctor or healthcare provider, even if you start feeling better.

Storing and Disposing of Your Medication

To maintain the quality and safety of your medication:

Store it at room temperature in a dry place, away from the bathroom.
Keep all medications in a secure location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist or healthcare provider. Check with your pharmacist for guidance on the best way to dispose of your medication, and consider participating in a drug take-back program in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Take the capsule whole; do not crush, chew, or divide. It can be taken with or without food, but taking it with food may help reduce stomach upset.
  • Avoid alcohol while taking this medication, as it can increase side effects like drowsiness and dizziness.
  • Be cautious when driving or operating machinery until you know how this medication affects you, as it may cause dizziness or drowsiness.
  • Do not stop taking this medication suddenly without consulting your doctor, as it can lead to withdrawal symptoms (e.g., dizziness, nausea, headache, anxiety). Your doctor will guide you on how to slowly reduce the dose if needed.
  • Inform your doctor about all other medications, supplements, and herbal products you are taking, especially St. John's Wort, triptans, or other antidepressants, to avoid serious interactions like serotonin syndrome.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Initial: 37.5 mg orally once daily for 4-7 days, then increase to 75 mg orally once daily. May increase by 75 mg/day increments at intervals of no less than 4 days.
Dose Range: 37.5 - 225 mg

Condition-Specific Dosing:

Major Depressive Disorder (MDD): Initial: 37.5 mg/day for 4-7 days, then 75 mg/day. Max: 225 mg/day.
Generalized Anxiety Disorder (GAD): Initial: 37.5 mg/day for 4-7 days, then 75 mg/day. Max: 225 mg/day.
Social Anxiety Disorder (SAD): Initial: 75 mg/day. Max: 225 mg/day.
Panic Disorder (PD): Initial: 37.5 mg/day for 7 days, then 75 mg/day. Max: 225 mg/day.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for routine use; safety and efficacy not established in pediatric patients for MDD, GAD, SAD, or PD. Black Box Warning for suicidality.
Adolescent: Not established for routine use; safety and efficacy not established in pediatric patients for MDD, GAD, SAD, or PD. Black Box Warning for suicidality.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: CrCl 30-60 mL/min: Reduce total daily dose by 25-50%.
Moderate: CrCl <30 mL/min: Reduce total daily dose by 50%.
Severe: CrCl <30 mL/min: Reduce total daily dose by 50%.
Dialysis: Reduce total daily dose by 50%. Administer after dialysis session.

Hepatic Impairment:

Mild: Child-Pugh A: Reduce total daily dose by 50%.
Moderate: Child-Pugh B: Reduce total daily dose by 50%.
Severe: Child-Pugh C: Reduce total daily dose by 50% or more (e.g., 75%). Individualize dosing.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are potent inhibitors of neuronal serotonin and norepinephrine reuptake and a weak inhibitor of dopamine reuptake. The antidepressant and anxiolytic effects are believed to be related to the potentiation of neurotransmitter activity in the CNS.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 45% (venlafaxine); ODV bioavailability is higher (~92%).
Tmax: Venlafaxine: 5.5 hours (ER); ODV: 9 hours (ER).
FoodEffect: Food has no significant effect on the absorption or Cmax of venlafaxine or ODV.

Distribution:

Vd: Approximately 7.5 L/kg (venlafaxine); 5.7 L/kg (ODV).
ProteinBinding: Approximately 27% (venlafaxine); 30% (ODV).
CnssPenetration: Yes

Elimination:

HalfLife: Venlafaxine: Approximately 5 hours; ODV: Approximately 11 hours.
Clearance: Venlafaxine: 1.3 Âą 0.6 L/h/kg; ODV: 0.4 Âą 0.2 L/h/kg.
ExcretionRoute: Renal (primarily as metabolites, with small amounts of unchanged drug).
Unchanged: Approximately 5% (venlafaxine); 29% (ODV) excreted unchanged in urine.
âąī¸

Pharmacodynamics

OnsetOfAction: Initial effects may be seen within 1-2 weeks; full therapeutic effects may take 4-6 weeks.
PeakEffect: Not precisely defined for clinical effect; plasma concentrations reach steady state within 3 days (venlafaxine) and 4-5 days (ODV) with multiple dosing.
DurationOfAction: Approximately 24 hours due to extended-release formulation and half-life of active metabolite.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of venlafaxine extended-release capsules or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond 24 years of age; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Venlafaxine extended-release capsules are not approved for use in pediatric patients.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of low sodium levels, including:
+ Headache
+ Trouble focusing or memory problems
+ Feeling confused or weak
+ Seizures or changes in balance
Signs of bleeding, such as:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding from the gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that enlarge
+ Uncontrollable bleeding
Signs of high blood pressure, including:
+ Severe headache or dizziness
+ Fainting or changes in eyesight
Seizures
Chest pain or pressure
Shortness of breath
Cough
Bone pain
Sexual problems, such as:
+ Decreased interest in sex
+ Difficulty having an orgasm
+ Ejaculation problems
+ Trouble getting or maintaining an erection
A potentially life-threatening condition called serotonin syndrome, which may be more likely if you take certain other medications. Seek medical help immediately if you experience:
+ Agitation
+ Changes in balance
+ Confusion
+ Hallucinations
+ Fever
+ Fast or abnormal heartbeat
+ Flushing
+ Muscle twitching or stiffness
+ Seizures
+ Shivering or shaking
+ Excessive sweating
+ Severe diarrhea, stomach upset, or vomiting
+ Severe headache

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or if they persist or bother you, contact your doctor:

Difficulty sleeping
Feeling nervous, excitable, or anxious
Weight loss
Dizziness, drowsiness, tiredness, or weakness
Shakiness
Headache
Excessive sweating
Constipation, diarrhea, stomach upset, vomiting, or decreased appetite
Gas
Dry mouth
Strange or unusual dreams
* Yawning

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Signs of serotonin syndrome: agitation, hallucinations, rapid heart rate, fever, sweating, shivering, muscle stiffness or twitching, loss of coordination, nausea, vomiting, diarrhea.
  • Worsening depression or suicidal thoughts, especially at the beginning of treatment or after a dose change.
  • New or worsening anxiety, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, restlessness, or mania/hypomania.
  • Severe allergic reaction (rash, hives, swelling of face/lips/tongue, difficulty breathing).
  • New or worsening eye pain, changes in vision, or swelling or redness in or around the eye (may indicate angle-closure glaucoma).
  • Unusual bleeding or bruising.
  • Seizures.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions and situations to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reactions you experienced.
If you have high blood pressure, as this medication may affect your condition.
If you have narrow-angle glaucoma, a condition that affects the pressure in your eyes.
If you are taking a weight loss drug, as this may interact with the medication.
If you are taking or have recently taken certain medications, including:
+ Linezolid or methylene blue, as these can cause serious interactions.
+ Certain drugs for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, within the last 14 days. Combining these medications can lead to very high blood pressure.
Other health problems or medications (prescription, over-the-counter, natural products, or vitamins) you are taking, as this medication may interact with them.

Remember, this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to discuss all your medications and health conditions with your doctor and pharmacist. Never start, stop, or change the dose of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This will help ensure your safety and prevent potential interactions with other treatments.

Until you know how this medication affects you, avoid driving and other activities that require alertness. If you need to stop taking this medication, do not do so abruptly without consulting your doctor, as this may increase your risk of side effects, which can be severe and long-lasting. Instead, follow your doctor's instructions for a gradual discontinuation.

Regular monitoring of your blood pressure is crucial while taking this medication, as it may cause high blood pressure. Follow your doctor's recommendations for blood pressure checks.

To minimize potential risks, avoid consuming alcohol while taking this medication. Additionally, consult your doctor before using marijuana, cannabis, or any prescription or over-the-counter drugs that may cause drowsiness or slow your reactions.

This medication may increase your risk of bleeding, which can be life-threatening in some cases. Discuss this risk with your doctor, especially if you have any concerns.

If you have bipolar disorder, be aware that this medication may trigger manic episodes. Contact your doctor immediately if you experience symptoms of a manic episode.

Some individuals may be at a higher risk of eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, seek medical attention promptly.

Low blood sodium levels (hyponatremia) can occur with this medication, and in severe cases, this can be fatal. Discuss this risk with your doctor and monitor your condition closely.

High cholesterol has been reported in some individuals taking this medication. If you have concerns or questions, consult your doctor.

This medication may affect the results of certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this medication to ensure accurate test results.

You may notice remnants of the medication in your stool, but this is a normal occurrence and not a cause for concern.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

In children and adolescents, this medication may affect growth in some cases. Regular growth checks may be necessary, so discuss this with your doctor.

If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor to discuss the potential benefits and risks to you and your baby. Taking this medication in mid to late pregnancy may increase the risk of health problems for both the mother (such as postpartum bleeding) and the newborn. If you are breastfeeding, your doctor will help you weigh the potential risks to your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Somnolence
  • Tachycardia
  • Mydriasis
  • Convulsions
  • Vomiting
  • ECG changes (e.g., QT prolongation, bundle branch block, QRS prolongation)
  • Hypotension
  • Coma
  • Death

What to Do:

Seek immediate medical attention or call 911. Contact a poison control center (1-800-222-1222). There is no specific antidote. Treatment should be supportive and symptomatic, including maintaining an adequate airway, oxygenation, and ventilation. Activated charcoal may be considered. Gastric lavage may be indicated soon after ingestion. Monitor cardiac rhythm and vital signs.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) (concurrent use or within 14 days of stopping MAOI, or starting MAOI within 7 days of stopping venlafaxine)
🔴

Major Interactions

  • Linezolid
  • Methylene blue
  • Other serotonergic drugs (e.g., SSRIs, SNRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, St. John's Wort) - increased risk of serotonin syndrome
  • Warfarin (increased bleeding risk)
  • Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, antipsychotics, macrolide antibiotics)
🟡

Moderate Interactions

  • Cimetidine (may increase venlafaxine levels)
  • Haloperidol (may increase haloperidol levels)
  • Metoprolol (may increase metoprolol levels)
  • Ethanol (alcohol) - may increase CNS depression and impair psychomotor skills
  • Drugs affecting CYP2D6 (e.g., quinidine, fluoxetine, paroxetine) - may increase venlafaxine levels and decrease ODV levels
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Blood Pressure

Rationale: Venlafaxine can cause dose-related sustained increases in blood pressure.

Timing: Prior to initiation of therapy.

Heart Rate

Rationale: Can cause increases in heart rate.

Timing: Prior to initiation of therapy.

Weight

Rationale: Monitor for significant weight changes (loss or gain).

Timing: Prior to initiation of therapy.

Psychiatric Assessment (mood, anxiety, suicidal ideation)

Rationale: To establish baseline symptom severity and monitor for worsening depression or emergence of suicidal thoughts/behaviors.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Blood Pressure

Frequency: Regularly, especially during dose titration and periodically thereafter.

Target: Normotensive range; individualize based on patient's baseline.

Action Threshold: Significant or sustained elevation requiring intervention (e.g., dose reduction, discontinuation, or antihypertensive therapy).

Heart Rate

Frequency: Periodically.

Target: Normal range.

Action Threshold: Clinically significant tachycardia.

Weight

Frequency: Periodically.

Target: Stable weight.

Action Threshold: Significant or rapid weight changes.

Psychiatric Assessment (mood, anxiety, suicidal ideation, behavioral changes)

Frequency: Weekly during initial treatment (first 4 weeks), then every 2-4 weeks for the first 12 weeks, and periodically thereafter.

Target: Improvement in target symptoms; absence of suicidal ideation or agitation.

Action Threshold: Worsening depression, emergence of suicidal thoughts/behaviors, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, akathisia, hypomania, or mania.

Serum Sodium

Frequency: Periodically, especially in elderly, volume-depleted, or those on diuretics.

Target: 135-145 mEq/L.

Action Threshold: Hyponatremia (Na <135 mEq/L), especially severe (<125 mEq/L).

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Emergence of suicidal thoughts or behaviors
  • Unusual changes in behavior (e.g., agitation, irritability, hostility, impulsivity)
  • Manic or hypomanic episodes
  • Serotonin syndrome (e.g., agitation, hallucinations, delirium, coma, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, tremor, rigidity, myoclonus, hyperreflexia, incoordination, GI symptoms)
  • Withdrawal symptoms upon discontinuation (e.g., dizziness, headache, nausea, vomiting, insomnia, nightmares, paresthesias, anxiety, agitation, tremor, sweating, flu-like symptoms)
  • New or worsening visual problems (e.g., angle-closure glaucoma)
  • Seizures

Special Patient Groups

🤰

Pregnancy

Use during pregnancy should be considered only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to SNRIs late in the third trimester have developed complications requiring prolonged hospitalization, respiratory support, and tube feeding. These complications can arise immediately upon delivery.

Trimester-Specific Risks:

First Trimester: Limited data, but generally not associated with major congenital malformations.
Second Trimester: Limited data.
Third Trimester: Risk of persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome (e.g., respiratory distress, cyanosis, apnea, seizures, feeding difficulties, tremor, irritability, constant crying).
🤱

Lactation

Venlafaxine and its active metabolite (ODV) are excreted into human milk. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the mother's clinical need for venlafaxine, and any potential adverse effects on the breastfed infant from venlafaxine or from the underlying maternal condition. Monitor infants for sedation, poor feeding, and poor weight gain.

Infant Risk: L3 (Moderately Safe) - Monitor infant for adverse effects. Some reports of irritability, crying, and sleep disturbances in breastfed infants.
đŸ‘ļ

Pediatric Use

Not approved for use in pediatric patients. Black Box Warning regarding increased risk of suicidal thinking and behavior in children, adolescents, and young adults. Efficacy and safety have not been established in this population for MDD, GAD, SAD, or PD.

👴

Geriatric Use

No overall differences in safety or effectiveness were observed between geriatric and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Dosage adjustments may be necessary due to age-related decreases in renal and hepatic function. Increased risk of hyponatremia and falls.

Clinical Information

💎

Clinical Pearls

  • Venlafaxine ER capsules should be swallowed whole; they contain spheroids that release the drug slowly. Patients may notice these spheroids in their stool, which is normal and does not indicate a lack of absorption.
  • Blood pressure should be monitored regularly, especially during dose escalation, as venlafaxine can cause dose-dependent increases in blood pressure.
  • Discontinuation syndrome is common with venlafaxine due to its relatively short half-life. Doses should be tapered gradually over several weeks to months to minimize withdrawal symptoms.
  • Serotonin syndrome is a rare but potentially life-threatening risk, especially when co-administered with other serotonergic agents. Educate patients on symptoms and advise immediate medical attention if they occur.
  • Patients should be monitored for activation of mania/hypomania, especially those with a history of bipolar disorder.
  • Venlafaxine can cause mydriasis and has been associated with angle-closure glaucoma; patients with a history of narrow-angle glaucoma should be monitored.
🔄

Alternative Therapies

  • Other SNRIs (e.g., Duloxetine, Desvenlafaxine, Levomilnacipran)
  • SSRIs (e.g., Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram)
  • Atypical antidepressants (e.g., Bupropion, Mirtazapine)
  • Tricyclic Antidepressants (TCAs) (e.g., Amitriptyline, Nortriptyline)
  • Other anxiolytics (e.g., Buspirone, benzodiazepines for short-term use)
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 capsules (37.5mg)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe and effective treatment, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information. It is vital to read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about this medication, consult with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information, including the name of the medication taken, the amount, and the time it occurred.